Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144294 · ClinicalTrials.gov registry record · NA
Whole-Body Hyperthermia for Mood and Anxiety Disorders
A NA study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06144294: Clinical Trial NA study, sponsored by Weill Medical College of Cornell University.
NCT06144294 is a NA study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06144294, a NA study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study aims to examine the scientific mechanisms of whole-body hyperthermia (WBH), a novel, rapidly acting, single session antidepressant and anxiolytic therapy. It also aims to determine its feasibility and acceptability in women with postpartum depression (PPD). The study will enroll four cohorts of participants: healthy postpartum controls; postpartum women with PPD; healthy adult controls; and adults with major depressive disorder or anxiety disorders in a longitudinal protocol.
Primary Outcome
Measure the extent of broad-band neural suppression in WBH.
Interventions
- DIAGNOSTIC_TEST fMRI
- OTHER Whole-Body Hyperthermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2028-06 |
| Est. Completion | 2032-12 |
| Phase | NA |
What is known before NCT06144294 opens enrollment
NCT06144294 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which fMRI is the first listed.
NCT06144294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06144294 about?
NCT06144294 is a clinical study titled "Whole-Body Hyperthermia for Mood and Anxiety Disorders". This study aims to examine the scientific mechanisms of whole-body hyperthermia (WBH), a novel, rapidly acting, single session antidepressant and anxiolytic therapy. It also aims to determine its feasibility and acceptability in women with postpartum depression (PPD). The study will enroll four coho...
What is the current status of trial NCT06144294?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2028-06. Estimated completion is 2032-12.
What interventions are being tested in trial NCT06144294?
The interventions under investigation include: fMRI (DIAGNOSTIC_TEST), Whole-Body Hyperthermia (OTHER).
Who is sponsoring clinical trial NCT06144294?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06144294's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia